Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA vs RAYMED LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANDU PHARMA RAYMED LABS SANDU PHARMA/
RAYMED LABS
 
P/E (TTM) x 48.5 -7.1 - View Chart
P/BV x 1.4 - - View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 SANDU PHARMA   RAYMED LABS
EQUITY SHARE DATA
    SANDU PHARMA
Mar-23
RAYMED LABS
Mar-23
SANDU PHARMA/
RAYMED LABS
5-Yr Chart
Click to enlarge
High Rs862 4,215.7%   
Low Rs501 3,372.5%   
Sales per share (Unadj.) Rs67.60-  
Earnings per share (Unadj.) Rs1.6-0.4 -393.2%  
Cash flow per share (Unadj.) Rs2.1-0.4 -545.7%  
Dividends per share (Unadj.) Rs0.750-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs40.6-5.4 -752.2%  
Shares outstanding (eoy) m9.664.27 226.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.00-  
Avg P/E ratio x43.3-4.4 -981.3%  
P/CF ratio (eoy) x32.3-4.6 -708.9%  
Price / Book Value ratio x1.7-0.3 -512.8%  
Dividend payout %47.60-   
Avg Mkt Cap Rs m6588 8,726.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1110 29,197.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6530-  
Other income Rs m30 1,557.1%   
Total revenues Rs m6570 312,742.9%   
Gross profit Rs m25-2 -1,336.6%  
Depreciation Rs m50 10,340.0%   
Interest Rs m10-   
Profit before tax Rs m22-2 -1,296.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m70-   
Profit after tax Rs m15-2 -889.5%  
Gross profit margin %3.80- 
Effective tax rate %31.40-   
Net profit margin %2.30- 
BALANCE SHEET DATA
Current assets Rs m2550 510,900.0%   
Current liabilities Rs m1391 15,425.6%   
Net working cap to sales %17.80- 
Current ratio x1.80.1 3,312.0%  
Inventory Days Days650- 
Debtors Days Days2680- 
Net fixed assets Rs m2862 18,954.3%   
Share capital Rs m9743 226.0%   
"Free" reserves Rs m296-66 -449.6%   
Net worth Rs m392-23 -1,701.7%   
Long term debt Rs m00-   
Total assets Rs m5422 34,721.8%  
Interest coverage x28.70-  
Debt to equity ratio x00-  
Sales to assets ratio x1.20-   
Return on assets %3.0-109.5 -2.7%  
Return on equity %3.97.4 52.3%  
Return on capital %5.97.4 79.0%  
Exports to sales %00-  
Imports to sales %00-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m2-2 -134.8%  
From Investments Rs m52 327.4%  
From Financial Activity Rs m6NA-  
Net Cashflow Rs m130-  

Share Holding

Indian Promoters % 42.9 28.4 151.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.0 1.0%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 57.1 71.6 79.7%  
Shareholders   10,021 1,498 669.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANDU PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SANDU PHARMA vs RAYMED LABS.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SANDU PHARMA vs RAYMED LABS. Share Price Performance

Period SANDU PHARMA RAYMED LABS. S&P BSE HEALTHCARE
1-Day -1.13% 0.00% 1.18%
1-Month -15.66% 3.32% -0.75%
1-Year 8.99% 6.86% 61.82%
3-Year CAGR 19.03% 31.90% 18.16%
5-Year CAGR 20.97% -1.90% 19.79%

* Compound Annual Growth Rate

Here are more details on the SANDU PHARMA share price and the RAYMED LABS. share price.

Moving on to shareholding structures...

The promoters of SANDU PHARMA hold a 42.9% stake in the company. In case of RAYMED LABS. the stake stands at 28.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SANDU PHARMA and the shareholding pattern of RAYMED LABS..

Finally, a word on dividends...

In the most recent financial year, SANDU PHARMA paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 47.6%.

RAYMED LABS. paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of SANDU PHARMA, and the dividend history of RAYMED LABS..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.